Tradewinds Capital Management’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-48
Closed -$3K 829
2021
Q4
$3K Hold
48
﹤0.01% 647
2021
Q3
$2K Hold
48
﹤0.01% 667
2021
Q2
$2K Hold
48
﹤0.01% 675
2021
Q1
$2K Hold
48
﹤0.01% 644
2020
Q4
$2K Hold
48
﹤0.01% 609
2020
Q3
$2K Hold
48
﹤0.01% 584
2020
Q2
$1K Hold
48
﹤0.01% 622
2020
Q1
$1K Sell
48
-60
-56% -$1.73K ﹤0.01% 618
2019
Q4
$3K Hold
108
﹤0.01% 568
2019
Q3
$3K Hold
108
﹤0.01% 498
2019
Q2
$3K Hold
108
﹤0.01% 496
2019
Q1
$3K Hold
108
﹤0.01% 511
2018
Q4
$2K Buy
+108
New +$2.77K ﹤0.01% 560

Other funds holding RXL

Tradewinds Capital Management's RXL Position: Q1 2022 in Review

Tradewinds Capital Management sold out of ProShares Ultra Health Care (RXL) in Q1 2022, closing a stake of 48 shares — an estimated $3K sold.

Tradewinds Capital Management first reported a position in RXL in Q4 2018 and held it in 13 quarters. The position peaked at $3K in Q4 2021. 22 funds tracked by Wall St. Rank hold RXL as of Q1 2022.

  • Tradewinds Capital Management reported no remaining ProShares Ultra Health Care position as of Q1 2022 after selling out during the quarter.
  • Tradewinds Capital Management sold 48 ProShares Ultra Health Care shares in Q1 2022, an estimated $3K.
  • Tradewinds Capital Management first reported a position in ProShares Ultra Health Care in Q4 2018 and held it in 13 quarters.
  • Tradewinds Capital Management's ProShares Ultra Health Care position peaked at $3K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2022.

Based on Tradewinds Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.